Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

114.95
-3.2450-2.75%
Post-market: 115.700.7500+0.65%19:59 EDT
Volume:988.64K
Turnover:115.75M
Market Cap:10.01B
PE:-22.03
High:120.26
Open:117.69
Low:114.50
Close:118.20
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:76.46M
Volume Ratio:1.20
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2168
EPS(LYR):-5.6758
ROE:-157.07%
ROA:-44.65%
PB:19.95
PE(LYR):-20.25

Loading ...

Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 07

Movement Alert|Abivax S.A. Falls 5.49% in Regular Trading, Phase 3 Trial Cancer Case Safety Concerns Continue to Weigh on Shares

Market Focus
·
Jun 05

Movement Alert|Abivax S.A. Rises 5.65% in Regular Trading, Extending Rebound After Phase 3 Trial Cancer Scare Triggered 40%+ Selloff

Market Focus
·
Jun 04

This Is Why Abivax Stock (ABVX) Is Up Today

TIPRANKS
·
Jun 04

Abivax price target lowered to $136 from $176 at Wolfe Research

TIPRANKS
·
Jun 04

Abivax rises 14.1%

TIPRANKS
·
Jun 03

Movement Alert|Abivax S.A. Rises 16.03% in Regular Trading, Partial Rebound After Phase 3 Trial Cancer Cases Triggered 40% Plunge

Market Focus
·
Jun 03

Movement Alert|Abivax S.A. Rises 6.21% in Pre-Market Trading, Partial Rebound After Phase 3 Trial Cancer Concerns Triggered 40% Crash

Market Focus
·
Jun 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)

TIPRANKS
·
Jun 03

Movement Alert|Abivax S.A. Rises 5.28% Overnight, Partial Rebound After 40% Crash on Phase 3 Trial Cancer Safety Concerns

Market Focus
·
Jun 03

Movement Alert|Abivax S.A. Rises 5.12% in After-Hours Trading, Modest Rebound Following 40% Intraday Plunge on Phase 3 Cancer Safety Concerns

Market Focus
·
Jun 03

Top Midday Decliners

MT Newswires Live
·
Jun 03

Sector Update: Healthcare Stocks Fall in Afternoon Trading

MT Newswires Live
·
Jun 03

Abivax falls -40.3%

TIPRANKS
·
Jun 03

Abivax Faces Increasing Risk of Black Box Warning for Obefazimod, Wedbush Says

MT Newswires Live
·
Jun 02

Abivax price target lowered to $135 from $140 at Truist

TIPRANKS
·
Jun 02

Movement Alert|Abivax S.A. Falls 40.7% in Regular Trading, Phase 3 Trial Data Complicated by Cancer Cases Triggers Market Panic

Market Focus
·
Jun 02

Leerink Partners Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 02

Top Premarket Decliners

MT Newswires Live
·
Jun 02